세계의 유전자 편집 기술 시장 : 제공, 기술, 용도, 최종 사용자별 예측(2025-2030년)

The Gene Editing Technologies Market was valued at USD 5.12 billion in 2023, expected to reach USD 5.73 billion in 2024, and is projected to grow at a CAGR of 12.57%, to USD 11.74 billion by 2030.

Gene editing technologies encompass a range of molecular tools that enable targeted modifications to the DNA of organisms, offering transformative potential across various domains. The necessity of these technologies lies in their precision and efficiency in addressing genetic disorders, improving agricultural crops, and enhancing biotechnological processes. Applications span healthcare, agriculture, and industrial biotechnology. In healthcare, gene editing holds promise for curing genetic diseases, developing personalized medicine, and advancing regenerative medicine. In agriculture, these technologies facilitate the development of crops with improved yield, resistance to pests and diseases, and tolerance to adverse conditions. Meanwhile, industrial applications include biofuel production and fermentation processes. A critical growth driver is the increasing prevalence of genetic and chronic diseases necessitating advanced therapeutic solutions, alongside the global food security challenge propelling advancements in crop modification. The burgeoning field of synthetic biology further boosts demand for gene editing tools. Opportunities lie in leveraging CRISPR technology and its derivatives to push boundaries in therapeutic solutions and crop engineering, with continuous investments and partnerships in research. However, limitations include ethical concerns, regulatory hurdles, and potential off-target effects that may lead to unforeseen genetic changes, which remain a significant challenge. Addressing public and regulatory apprehensions through transparent stakeholder communication and robust ethical frameworks is vital for market expansion. Innovation should focus on refining precision and specificity of gene-editing tools, developing delivery systems for therapeutic applications, and expanding the bioinformatics infrastructure for better genomic data analysis. Market dynamics are characterized by rapid advancements but with caution due to potential biopolitical controversies. These technologies represent a burgeoning area of research and commercial interest, where strategic partnerships, continuous R&D investment, and adherence to ethical standards will be critical for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Editing Technologies Market

The Gene Editing Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of genetic disorders worldwide
  • Increasing investments for R&D in gene editing
  • Significant improvements in CRISPR-based tools
• Market Restraints
  • High cost of development of gene editing technologies
• Market Opportunities
  • Technological advancements in gene editing technologies
  • Inclination toward personalized medicine approach
• Market Challenges
  • Ethical concerns and stringent regulatory framework

Porter's Five Forces: A Strategic Tool for Navigating the Gene Editing Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Editing Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Editing Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Editing Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Editing Technologies Market

A detailed market share analysis in the Gene Editing Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Editing Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Editing Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Editing Technologies Market

A strategic analysis of the Gene Editing Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Editing Technologies Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AMS Biotechnology Ltd., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis SA, Creative Biogene, CRISPR Therapeutics AG, Editas Medicine, Inc., GenScript Biotech Corporation, Horizon Discovery Ltd., Inscripta, Inc., Integrated DNA Technologies, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck Group, New England Biolabs, Inc., OriGene Technologies, Inc., Precision BioSciences, Inc., Sangamo Therapeutics, Inc., Synthego Corporation, Takara Bio Inc., Tecan Trading AG, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Gene Editing Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Reagents & Consumables, Services, and Software & Systems.
• Based on Technology, market is studied across Antisense, CRISPR, Talen, and Zinc Finger Nucleases (ZFN).
• Based on Application, market is studied across Animal Genetic Engineering, Cell Line Engineering, Genetic Engineering, and Plant Genetic Engineering.
• Based on End User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of genetic disorders worldwide
    • 5.1.1.2. Increasing investments for R&D in gene editing
    • 5.1.1.3. Significant improvements in CRISPR-based tools
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of development of gene editing technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in gene editing technologies
    • 5.1.3.2. Inclination toward personalized medicine approach
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical concerns and stringent regulatory framework
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gene Editing Technologies Market, by Offering

• 6.1. Introduction
• 6.2. Reagents & Consumables
• 6.3. Services
• 6.4. Software & Systems

7. Gene Editing Technologies Market, by Technology

• 7.1. Introduction
• 7.2. Antisense
• 7.3. CRISPR
• 7.4. Talen
• 7.5. Zinc Finger Nucleases (ZFN)

8. Gene Editing Technologies Market, by Application

• 8.1. Introduction
• 8.2. Animal Genetic Engineering
• 8.3. Cell Line Engineering
• 8.4. Genetic Engineering
• 8.5. Plant Genetic Engineering

9. Gene Editing Technologies Market, by End User

• 9.1. Introduction
• 9.2. Academic & Government Research Institutes
• 9.3. Biotechnology & Pharmaceutical Companies
• 9.4. Contract Research Organizations

10. Americas Gene Editing Technologies Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Gene Editing Technologies Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Gene Editing Technologies Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. AMS Biotechnology Ltd.
• 3. Beam Therapeutics Inc.
• 4. Caribou Biosciences, Inc.
• 5. Cellectis SA
• 6. Creative Biogene
• 7. CRISPR Therapeutics AG
• 8. Editas Medicine, Inc.
• 9. GenScript Biotech Corporation
• 10. Horizon Discovery Ltd.
• 11. Inscripta, Inc.
• 12. Integrated DNA Technologies, Inc.
• 13. Intellia Therapeutics, Inc.
• 14. Lonza Group Ltd.
• 15. Mammoth Biosciences, Inc.
• 16. Merck Group
• 17. New England Biolabs, Inc.
• 18. OriGene Technologies, Inc.
• 19. Precision BioSciences, Inc.
• 20. Sangamo Therapeutics, Inc.
• 21. Synthego Corporation
• 22. Takara Bio Inc.
• 23. Tecan Trading AG
• 24. Thermo Fisher Scientific, Inc.